Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients

[1]  A. Conigliaro,et al.  Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs. , 2019, Carcinogenesis.

[2]  Jun-Miao Zhu,et al.  Bone marrow‐derived mesenchymal stem cell‐derived exosomal microRNA‐208a promotes osteosarcoma cell proliferation, migration, and invasion , 2020, Journal of cellular physiology.

[3]  K. Pienta,et al.  Extracellular vesicle isolation from human renal cancer tissue , 2020, Medical Oncology.

[4]  Chi Wang,et al.  p300/CBP inhibition enhances the efficacy of programmed death-ligand 1 blockade treatment in prostate cancer , 2020, Oncogene.

[5]  Haotian Zhang,et al.  Nanosponges of circulating tumor-derived exosomes for breast cancer metastasis inhibition. , 2020, Biomaterials.

[6]  N. Tumino,et al.  Characterization of Human NK Cell-Derived Exosomes: Role of DNAM1 Receptor in Exosome-Mediated Cytotoxicity against Tumor , 2020, Cancers.

[7]  Lingling Wu,et al.  Homogeneous, Low-volume, Efficient and Sensitive Quantitation of Circulating Exosomal PD-L1 for Cancer Diagnosis and Immunotherapy Response Prediction. , 2020, Angewandte Chemie.

[8]  C. Garrido,et al.  Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients , 2020, Journal of extracellular vesicles.

[9]  Ò. M. Tirado,et al.  Exosomes in Bone Sarcomas: Key Players in Metastasis , 2020, Cells.

[10]  Sheng-lin Wang,et al.  A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro , 2019, International journal of nanomedicine.

[11]  R. Blelloch,et al.  Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory , 2019, Cell.

[12]  M. Sydes,et al.  Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort , 2019, European journal of cancer.

[13]  Wei Zhang,et al.  Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response , 2018, Nature.

[14]  W. Guo,et al.  PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse , 2018, Journal of Hematology & Oncology.

[15]  O. Taratula,et al.  Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells , 2017, Experimental cell research.

[16]  Si-ying Zhou,et al.  Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer. , 2017, Gene.

[17]  S. Zappavigna,et al.  Non-coding RNAs as a new dawn in tumor diagnosis. , 2017, Seminars in cell & developmental biology.

[18]  T. Ochiya,et al.  Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma , 2017, Oncotarget.

[19]  L. Bujanda,et al.  Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have. , 2016, Annals of translational medicine.

[20]  J. Thiery,et al.  Exosome-Mediated Metastasis: From Epithelial-Mesenchymal Transition to Escape from Immunosurveillance. , 2016, Trends in pharmacological sciences.

[21]  Michael E. Egger,et al.  Melanoma cell-derived exosomes promote epithelial-mesenchymal transition in primary melanocytes through paracrine/autocrine signaling in the tumor microenvironment. , 2016, Cancer letters.

[22]  K. Selvendiran,et al.  The biological significance and clinical applications of exosomes in ovarian cancer. , 2016, Gynecologic oncology.

[23]  G. Stein,et al.  Proteomic Analysis of Exosomes and Exosome‐Free Conditioned Media From Human Osteosarcoma Cell Lines Reveals Secretion of Proteins Related to Tumor Progression , 2016, Journal of cellular biochemistry.

[24]  Jianqing Xu,et al.  Exosomes for Immunoregulation and Therapeutic Intervention in Cancer , 2016, Journal of Cancer.

[25]  J. Roa,et al.  Circulating MicroRNAs as Biomarkers in Biliary Tract Cancers , 2016, International journal of molecular sciences.

[26]  Hongling Li,et al.  Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway , 2016, Journal of Hematology & Oncology.

[27]  F. Wang,et al.  Exosomes derived from gefitinib-treated EGFR-mutant lung cancer cells alter cisplatin sensitivity via up-regulating autophagy , 2016, Oncotarget.

[28]  Clotilde Théry,et al.  Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.

[29]  Henrik J Johansson,et al.  Cells release subpopulations of exosomes with distinct molecular and biological properties , 2016, Scientific Reports.

[30]  T. Whiteside,et al.  Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets , 2016, Scientific Reports.

[31]  Meng Xu,et al.  The regulation of cancer cell migration by lung cancer cell-derived exosomes through TGF-β and IL-10. , 2016, Oncology letters.

[32]  G. Dawson,et al.  The hyaluronic acid inhibitor 4-methylumbelliferone is an NSMase2 activator-role of Ceramide in MU anti-tumor activity. , 2016, Biochimica et biophysica acta.

[33]  L. Bujanda,et al.  Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer. , 2016, Annals of translational medicine.

[34]  Guang-ning Yan,et al.  Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets. , 2016, Cancer letters.

[35]  S. Horie,et al.  Molecular Biomarkers in Bladder Cancer: Novel Potential Indicators of Prognosis and Treatment Outcomes , 2016, Disease markers.

[36]  R. Christopherson,et al.  Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples , 2016, Journal of extracellular vesicles.

[37]  T. Whiteside,et al.  Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer , 2016, Journal of extracellular vesicles.

[38]  L. Abid,et al.  Surface osteosarcoma: Clinical features and therapeutic implications , 2015, Journal of bone oncology.

[39]  P. Mukhopadhyay,et al.  Progression of Osteosarcoma from a Non-Metastatic to a Metastatic Phenotype Is Causally Associated with Activation of an Autocrine and Paracrine uPA Axis , 2015, PloS one.

[40]  E. Hurt,et al.  The Exosome Is Recruited to RNA Substrates through Specific Adaptor Proteins , 2015, Cell.

[41]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[42]  Cheng Wang,et al.  PI3K/Akt signaling in osteosarcoma. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[43]  P. Picci,et al.  MDM2 and CDK4 expression in periosteal osteosarcoma. , 2015, Human pathology.

[44]  V. Ponomarev,et al.  Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma. , 2015, Cancer letters.

[45]  Simon C Watkins,et al.  Isolation of biologically-active exosomes from human plasma. , 2014, Journal of immunological methods.

[46]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[47]  M. Sydes,et al.  Clinico-histologic parameters of osteosarcoma patients with late relapse. , 2006, European journal of cancer.

[48]  A. Cleton-Jansen,et al.  Central high-grade osteosarcoma of bone: Diagnostic and genetic considerations , 2005 .

[49]  Piero Picci,et al.  Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. , 2005, European journal of cancer.

[50]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[51]  N. Copeland,et al.  A mutation in Rab27a causes the vesicle transport defects observed in ashen mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[52]  L. Twiggs,et al.  Carcinoma of the uterine cervix FIGO Stage I-B. , 1982, Gynecologic oncology.

[53]  T. Whiteside.  Tumor-Derived Exosomes and Their Role in Cancer Progression. , 2016, Advances in clinical chemistry.

[54]  R. Luo,et al.  Immunosuppression of breast cancer cells mediated by transforming growth factor-β in exosomes from cancer cells. , 2016, Oncology letters.

[55]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..